Multivariate regression reveals linear correlation between ICU Klebsiella pneumoniae resistance and antibiotic use
DOI:
https://doi.org/10.3855/jidc.21704Keywords:
intensive care unit, Klebsiella pneumoniae, multiple linear regression analysis, linear correlationAbstract
Introduction: This study investigated the macro-quantitative correlation between Klebsiella pneumoniae resistance rates and concurrent antimicrobial use in the intensive care unit (ICU), to guide treatment for chronic refractory infections caused by this pathogen, by optimizing outcomes for critically ill patients while curbing bacterial resistance spread or transmission.
Methodology: A retrospective analysis was conducted on the resistance rate of K. pneumoniae and the concurrent use of antimicrobial agents in the ICU. A multiple linear regression model was employed to analyze whether there was an independent linear correlation between the two, and to identify the relevant factors.
Results: 936 K. pneumoniae isolates were identified in the ICU between 2020 and 2024, representing 20.45% (936/4,577) of all bacterial isolates recovered from the ICU. The resistance rates to most antimicrobial agents, except for tigecycline and trimethoprim-sulfamethoxazole, exceeded 65%, indicating a severe resistance situation. Multiple linear regression analysis revealed that the resistance rates of K. pneumoniae to imipenem, piperacillin-tazobactam, and ceftazidime were independently linear correlated only with piperacillin-tazobactam defined daily doses (DDDs), with regression coefficients (β) of 0.221, 0.224, and 0.166, respectively. The resistance rates to ceftriaxone, cefoperazone-sulbactam, and ertapenem were positively correlated with piperacillin-tazobactam DDDs. Resistance to cefepime was positively correlated with ceftazidime DDDs. Resistance to tigecycline was positively correlated with meropenem DDDs. Resistance to levofloxacin was negatively correlated with cefoperazone-sulbactam DDDs.
Conclusions: The resistance rate of K. pneumoniae in the ICU is closely related to antimicrobial use. Hospitals should strengthen the regulation of antimicrobial use to delay the emergence of drug-resistant species.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Fangyuan Xia, Yu Pan, Sucai Chen, Zhen Tao, Xiaohao Pan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
